Welcome
Harvard Ophthalmology is one of the leading and largest academic departments of ophthalmology in the nation. Formally established in 1871, the department is built upon a strong and rich foundation in medical education, research, and clinical care. Through the years, Harvard Ophthalmology faculty and alumni have profoundly influenced ophthalmic science, medicine, and literature—helping to transform the field of ophthalmology from a branch of surgery into an independent medical specialty at the forefront of science. Today, the department continues its legacy as one of the finest academic medical institutions in the world—teaching and mentoring future leaders, turning laboratory insight into cures, and bringing the fruits of its labors to patients' bedsides.
Ophthalmology News
- 2020 Annual and Alumni Virtual Meeting
- Congratulations to our 2020 Clinical Trainee Graduates
- Ankoor S.Shah, MD, PhD, Receives BCH Research Award
- David G. Hunter, MD, PhD, Recognized by Fast Company
- Grayson Armstrong, MD, MPH, Wins MIT Entrepreneurship Competition
- David G. Hunter, MD, PhD, Honored with Harvard Medical School Faculty Award
- Rohan Bir Singh, MD, Named Science Communication Training Fellow
- Petr Baranov, PhD, Receives 2020 Iraty Award for Research in Retinal Diseases
- Luk Vandenberghe, PhD, Leads COVID-19 Vaccine Development
Ophthalmology Newsletters
Eye Witness, Jan 2020
A newsletter that shares Harvard Ophthalmology's key accomplishments in research, education, and clinical care.
eye Insights, Jan 2020
A premier clinical practice newsletter for ophthalmologists published by Mass. Eye and Ear and Mass General Hospital.
Events Update
As part of our ongoing efforts to protect the health and safety of our community, some meetings and events have been postponed indefinitely. Please check the event calendar carefully or contact the event coordinator for more information.
Upcoming Events
@HMSeye
-
Proud to announce that we are entering into an exclusive agreement with @MassEyeAndEar to focus on developing a potential treatment for inherited retinal degeneration due to mutations in the PRPF31 gene. t.co/nS8njn1CRn
-
Excited to share that @MassEyeAndEar and faculty member Dr. Eric Pierce are collaborating with @biogen to develop a treatment for inherited retinal blindness due to mutations in the PRPF31 gene, one of the most common causes for retinitis pigmentosa. t.co/LvnYpSOXHn t.co/BPKekqsSag
-
A warm welcome to our new residents and clinical fellows starting today! t.co/NshfXk3alg
-
Fuchs research led by Dr. Ula Jurkunas indicates that UV light exposure is a physiological stressor of the disorder. This research, recently highlighted in @EyeWorldMag, provides new clues that may ultimately lead to better prevention and treatment. t.co/k0CLfAcbEv t.co/tgsZ5i67p9
